HighCape Capital Acquisition Corp. II

HighCape Capital Acquisition Corp. II (Nasdaq: HCCR) is a blank-check company sponsored by HighCape Capital LP, a New York-based investment firm with a focused track record in life sciences and healthcare. The company filed its S-1 registration statement with the SEC on March 10, 2021, targeting a business combination with a company operating in the healthcare or life sciences sector. HCCR represented HighCape's second SPAC vehicle, following its predecessor entity which completed a merger with next-generation sequencing firm Quantum-Si. The sponsor's healthcare specialization positioned HCCR within the wave of sector-specific SPACs that defined the 2021 capital markets environment. Sign up for a full SpacDesk account to access complete filing history, deal timelines, and sponsor analytics for HCCR and hundreds of other SPAC vehicles.